4.450
+0,00%
2026-10-19
Fundamental Analysis
65 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +122.2% | +48.4% | 2 / 3 | +10.5% | +0.27 pp | +0.60 pp | +6.6% | 1.47 | 5.45 | 1.082 | +10,5% | 25,3 | +48,5% | 5.45 | 12.54 | −56,5% |
| Pts | 12 | 12 | 8 | 4 | 8 | 8 | 0 | 6 | 12 | |||||||
Valuation annotation:Price: 4.450 (close price on 2026-10-19)EPS (TTM): 816,0
Financial charts
1.Revenue & growth
VND bn1.082Q2/26
1.Revenue & growth
VND bn1.082Q2/26
2.Profit & growth
VND bn18,7Q2/26
3.Profit mix (Penman)
VND bn127Q2/26
4.Margins & cost structure
%17.0%Q2/26
5.Returns & cash cycle
% · days6.3%Q2/26
6.Earnings quality & cash
VND bn197Q2/26
7.Asset structure
VND bn5.171Q2/26
8.Funding & debt health
VND bn · times5.171Q2/26
9.Revenue backlog
VND bn33,4Q2/26
10.Valuation
times · %5,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %184Q2/26
Adjusted EPS growth, latest quarter
122%
Average adjusted EPS growth, 3 quarters
48.4%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26